Hunan Er Kang Pharmaceutical (300267) — Financial Flexibility Index
Hunan Er Kang Pharmaceutical (300267) has a Financial Flexibility Index of 0.45x as of June 2023. Free cash flow of CN¥220.23 Million (operating CF CN¥174.55 Million minus capex CN¥45.68 Million) represents 0% of total liabilities (CN¥490.30 Million). Also explore Hunan Er Kang Pharmaceutical (300267) equity growth momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Hunan Er Kang Pharmaceutical Financial Flexibility Index (2008–2024)
Historical Financial Flexibility Index trend for Hunan Er Kang Pharmaceutical across 17 annual periods. Check Hunan Er Kang Pharmaceutical (300267) strategic asset index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Hunan Er Kang Pharmaceutical (2008–2024)
Year-by-year free cash flow to debt coverage for Hunan Er Kang Pharmaceutical. For the full company profile including market capitalisation, see 300267 market cap.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.45x | CN¥362.29 Million | CN¥166.69 Million | CN¥797.54 Million | ▼ -21.4% |
| 2023 | 0.58x | CN¥386.61 Million | CN¥148.42 Million | CN¥669.05 Million | ▲ +2.3% |
| 2022 | 0.56x | CN¥454.51 Million | CN¥281.02 Million | CN¥804.57 Million | ▼ -28.7% |
| 2021 | 0.79x | CN¥442.02 Million | CN¥92.68 Million | CN¥558.28 Million | ▼ -24.0% |
| 2020 | 1.04x | CN¥784.42 Million | CN¥178.53 Million | CN¥753.22 Million | ▼ -54.9% |
| 2019 | 2.31x | CN¥810.03 Million | CN¥445.82 Million | CN¥350.72 Million | ▲ +328.6% |
| 2018 | 0.54x | CN¥220.62 Million | CN¥123.89 Million | CN¥409.39 Million | ▼ -82.5% |
| 2017 | 3.07x | CN¥948.03 Million | CN¥689.11 Million | CN¥308.37 Million | ▼ -23.0% |
| 2016 | 3.99x | CN¥1.63 Billion | CN¥486.50 Million | CN¥408.94 Million | ▲ +99.3% |
| 2015 | 2.00x | CN¥1.09 Billion | CN¥518.96 Million | CN¥544.10 Million | ▲ +54.6% |
| 2014 | 1.30x | CN¥702.81 Million | CN¥175.38 Million | CN¥542.64 Million | ▼ -61.3% |
| 2013 | 3.35x | CN¥378.20 Million | CN¥174.22 Million | CN¥113.01 Million | ▼ -22.2% |
| 2012 | 4.30x | CN¥315.31 Million | CN¥84.02 Million | CN¥73.32 Million | ▲ +137.0% |
| 2011 | 1.81x | CN¥119.59 Million | CN¥75.72 Million | CN¥65.90 Million | ▲ +101.1% |
| 2010 | 0.90x | CN¥107.52 Million | CN¥42.47 Million | CN¥119.15 Million | ▲ +129.2% |
| 2009 | 0.39x | CN¥29.82 Million | CN¥10.18 Million | CN¥75.72 Million | ▲ +82.2% |
| 2008 | 0.22x | CN¥12.83 Million | CN¥211.00K | CN¥59.37 Million | — |